Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Investing can seem daunting for beginners. Understand the essential concepts to kickstart your investment journey.
17,710 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Politics and the Supreme Court can shape investment outcomes. This guide explains the potential financial impact of t...
As SpaceX eyes a historic float, investors are handed a high-stakes mix of dream-scale growth and sobering risk. This...
AMD has sprinted ahead in a rapid rally. This guide weighs whether the late advanced micro devices story still offers...
As rates rise, some brokers benefit from higher interest income. This piece explains how Interactive Brokers can gene...
For dividend kings long-term investors, a disciplined, income-forward approach can power wealth over two decades. Thi...
A fresh platform named For Traders is attracting attention as early reviews praise security and tools but flag costs ...
Explore how Uri Levine’s problem-first approach fuels startup success, from Waze’s ascent to the future of autonomous...
The term stagflation can spark fear, but panicking won’t help. This guide breaks down what stagflation starting rear ...
After an 11% drop, investors wonder if CoreWeave stock can rebound. This article weighs the bull and bear cases, what...
A leading DeFi security expert says AI-powered coding agents have made the space unsafe. The warning comes as attack ...
A Digi International VP sold a stake amid a fast-changing IoT landscape. This article breaks down what such insider m...